BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

ALLERGAN PLC — Lobbying — Receipts Report

LD-2 disclosure · Registration - Amendment

ALLERGAN PLC

via THE MCMANUS GROUP

3rd Quarter (July 1 - Sep 30) · 2013Posted Jul 20, 2015Filing document ↗LDA record ↗

Coverage · Registration amendment — updates registrant or client details already on file; not a periodic activity report.

Client

Name: ALLERGAN PLC
Description: Allergan is a diversified global pharmaceutical company
Location: New Jersey · United States of America

Registrant

Firm: THE MCMANUS GROUP
Description: Consulting
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
General health care coverage and reimbursement; issues related to infectious disease drug development, procurement and regulation.
LobbyistsJOHN MCMANUS · BARRETT THORNHILL · CHASE M THOMAS
Covered position (JOHN MCMANUS): Staff Director W&M; LA, Rep. Bill Thomas
Covered position (BARRETT THORNHILL): LA, Sen. Crapo & Rep. Toomey; LA & Press Secretary Rep. Norwood

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.